Revenue growth supported by solid demand for Canndoc’s branded products, strategic and exclusive partnerships and the expansion of its distribution and dispensary footprint – ‘GIVOL’ pharmacy chain.
CAD $68 million raised by successful completion of the SPAC merger with Subversive Acquisition LP and the LOI signed for the acquisition of Israeli medical cannabis LP ‘Better’ positions the company to further lead market consolidation as the fastest-growing, profitable cannabis company outside of North America.
The Company’s independent registered public accounting firm, Somekh Chaikin , has not audited, reviewed or performed any procedures with respect to the accompanying financial estimates and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto.
Such risks and uncertainties include, but are not limited to: changes in general economic, business and political conditions, changes in applicable laws, the Canadian regulatory landscapes and enforcement related to cannabis, changes in public opinion and perception of the cannabis industry, reliance on the expertise and judgment of senior management, as well as the factors discussed under the heading “Risk Factors” in Subversive Acquisition LP’s final long form prospectus dated March 15, 2021, which is available on SEDAR at www.sedar.com.